• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞移植后的操作耐受性具有独特的转录、表型和代谢特征。

Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signatures.

作者信息

Dubouchet Laetitia, Todorov Helena, Seurinck Ruth, Vallet Nicolas, Van Gassen Sofie, Corneau Aurélien, Blanc Catherine, Zouali Habib, Boland Anne, Deleuze Jean-François, Ingram Brian, de Latour Regis Peffault, Saeys Yvan, Socié Gérard, Michonneau David

机构信息

Université de Paris, INSERM U976, F-75010 Paris, France.

Data Mining and Modeling for Biomedicine, VIB Center for Inflammation Research, 9052 Ghent, Belgium.

出版信息

Sci Transl Med. 2022 Feb 23;14(633):eabg3083. doi: 10.1126/scitranslmed.abg3083.

DOI:10.1126/scitranslmed.abg3083
PMID:35196024
Abstract

The mechanisms underlying operational tolerance after hematopoietic stem cell transplantation in humans are poorly understood. We studied two independent cohorts of patients who underwent allogeneic hematopoietic stem cell transplantation from human leukocyte antigen-identical siblings. Primary tolerance was associated with long-lasting reshaping of the recipients' immune system compared to their healthy donors with an increased proportion of regulatory T cell subsets and decreased T cell activation, proliferation, and migration. Transcriptomics profiles also identified a role for nicotinamide adenine dinucleotide biosynthesis in the regulation of immune cell functions. We then compared individuals with operational tolerance and nontolerant recipients at the phenotypic, transcriptomic, and metabolomic level. We observed alterations centered on CD38-activated T and B cells in nontolerant patients. In tolerant patients, cell subsets with regulatory functions were prominent. RNA sequencing analyses highlighted modifications in the tolerant patients' transcriptomic profiles, particularly with overexpression of the ectoenzyme (encoding CD73), which could counterbalance CD38 enzymatic functions by producing adenosine. Further, metabolomic analyses suggested a central role of androgens in establishing operational tolerance. These data were confirmed using an integrative approach to evaluating the immune landscape associated with operational tolerance. Thus, balance between a CD38-activated immune state and CD73-related production of adenosine may be a key regulator of operational tolerance.

摘要

人类造血干细胞移植后产生操作耐受的潜在机制目前仍知之甚少。我们研究了两组独立的患者队列,这些患者均接受了来自人类白细胞抗原匹配同胞的异基因造血干细胞移植。与健康供体相比,原发性耐受与受者免疫系统的长期重塑有关,调节性T细胞亚群比例增加,T细胞活化、增殖和迁移减少。转录组学分析还确定了烟酰胺腺嘌呤二核苷酸生物合成在免疫细胞功能调节中的作用。然后,我们在表型、转录组和代谢组水平上比较了具有操作耐受的个体和无耐受的受者。我们观察到,在无耐受患者中,以CD38激活的T细胞和B细胞为中心的改变。在耐受患者中,具有调节功能的细胞亚群较为突出。RNA测序分析突出了耐受患者转录组谱的变化,特别是胞外酶(编码CD73)的过表达,其可通过产生腺苷来抵消CD38的酶促功能。此外,代谢组学分析表明雄激素在建立操作耐受中起核心作用。这些数据通过综合评估与操作耐受相关的免疫格局的方法得到了证实。因此,CD38激活的免疫状态与CD73相关的腺苷产生之间的平衡可能是操作耐受的关键调节因子。

相似文献

1
Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signatures.造血干细胞移植后的操作耐受性具有独特的转录、表型和代谢特征。
Sci Transl Med. 2022 Feb 23;14(633):eabg3083. doi: 10.1126/scitranslmed.abg3083.
2
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients.利用转录谱分析开发肝移植受者手术耐受的诊断测试。
J Clin Invest. 2008 Aug;118(8):2845-57. doi: 10.1172/JCI35342.
3
Genomic biomarkers correlate with HLA-identical renal transplant tolerance.基因组生物标志物与 HLA 相同的肾移植耐受相关。
J Am Soc Nephrol. 2013 Sep;24(9):1376-85. doi: 10.1681/ASN.2013010068. Epub 2013 Jun 20.
4
Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.人类白细胞抗原-G 的免疫调节功能及其在异基因造血干细胞移植后移植物抗宿主病中的作用。
Ann Hematol. 2021 Jun;100(6):1391-1400. doi: 10.1007/s00277-021-04486-z. Epub 2021 Mar 11.
5
Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.异基因造血干细胞移植后长期免疫重建和感染负担。
Biol Blood Marrow Transplant. 2014 Apr;20(4):507-17. doi: 10.1016/j.bbmt.2014.01.001. Epub 2014 Jan 7.
6
Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.HLA 同基因兄弟姐妹间联合肾和造血干细胞移植诱导特异性免疫耐受的成功。
Front Immunol. 2022 Jan 31;13:796456. doi: 10.3389/fimmu.2022.796456. eCollection 2022.
7
Impact of fetal-maternal tolerance in hematopoietic stem cell transplantation.胎儿-母体耐受性在造血干细胞移植中的影响。
Arch Immunol Ther Exp (Warsz). 2006 May-Jun;54(3):165-72. doi: 10.1007/s00005-006-0018-y. Epub 2006 May 2.
8
Facilitating cells: role in inducing transplantation tolerance.辅助细胞:在诱导移植耐受中的作用
Curr Opin Organ Transplant. 2018 Oct;23(5):546-551. doi: 10.1097/MOT.0000000000000563.
9
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.表达抑制性杀伤细胞免疫球蛋白样受体(KIR)以识别非自身配体的 NK 细胞在 HLA 匹配的同胞干细胞移植中保持耐受。
Blood. 2010 Apr 1;115(13):2686-94. doi: 10.1182/blood-2009-07-229740. Epub 2010 Jan 22.
10
Long-term immune reconstitution of naive and memory t cell pools after haploidentical hematopoietic stem cell transplantation.Haploidentical 造血干细胞移植后幼稚和记忆 T 细胞池的长期免疫重建。
Biol Blood Marrow Transplant. 2013 May;19(5):703-12. doi: 10.1016/j.bbmt.2013.01.017. Epub 2013 Feb 8.

引用本文的文献

1
NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update.美国国立卫生研究院2025年慢性移植物抗宿主病共识会议更新内容
Transplant Cell Ther. 2025 May 21. doi: 10.1016/j.jtct.2025.05.016.
2
Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib, or belumosudil in murine sclerodermatous GVHD.在小鼠硬皮病样移植物抗宿主病中,将豪猪抑制与鲁索替尼、伊布替尼或贝利莫司他联合治疗。
Blood Adv. 2025 Mar 25;9(6):1261-1266. doi: 10.1182/bloodadvances.2024014387.
3
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy Discontinuation.
儿科移植与细胞治疗联盟造血细胞移植后儿科慢性移植物抗宿主病生存的RESILIENT会议:第一部分。慢性移植物抗宿主病的阶段、支持治疗和全身治疗的中断
Transplant Cell Ther. 2025 Feb;31(2):69.e1-69.e18. doi: 10.1016/j.jtct.2024.12.011. Epub 2024 Dec 17.
4
Distinct Immune Homeostasis Remodeling Patterns after HLA-Matched and Haploidentical Transplantation.HLA 匹配和单倍体移植后不同的免疫稳态重塑模式。
Adv Sci (Weinh). 2024 Oct;11(39):e2400544. doi: 10.1002/advs.202400544. Epub 2024 Sep 3.
5
Unlocking Transplant Tolerance with Biomaterials.利用生物材料实现移植耐受
Adv Healthc Mater. 2025 Feb;14(5):e2400965. doi: 10.1002/adhm.202400965. Epub 2024 Jul 3.
6
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantation.接受干细胞移植的患者的肠道保护代谢物与细菌和噬菌体群落有关。
Nat Cancer. 2024 Jan;5(1):187-208. doi: 10.1038/s43018-023-00669-x. Epub 2024 Jan 3.
7
Milestones in acute GVHD pathophysiology.急性移植物抗宿主病发病机制的里程碑。
Front Immunol. 2022 Dec 5;13:1079708. doi: 10.3389/fimmu.2022.1079708. eCollection 2022.
8
Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.慢性移植物抗宿主病 NIH 共识项目生物学工作组:向慢性移植物抗宿主病个体化治疗的演进之路。
Blood Adv. 2023 Sep 12;7(17):4886-4902. doi: 10.1182/bloodadvances.2022007611.